Non-coding RNA: From gene expression regulation to precision medicine and modern therapeutic applications – A comprehensive scientific review
DOI:
https://doi.org/10.64943/ljacs.2026.010209Keywords:
Non-coding RNA, precision medicine, gene therapy, microRNA, circular RNA, siRNA therapeutics, RNA deliveryAbstract
Recently, there has been a surge of interest in understanding gene regulation following the discovery that a significant portion of the human genome does not code for proteins but rather produces molecules of non-coding RNA (ncRNA) that perform complex and essential regulatory functions in various cellular processes. This discovery overturned the previously held belief that ncRNA was a functionless nucleic acid. Modern studies have demonstrated that these molecules are among the most important regulators of gene expression at the transcriptional, post-transcriptional, and epigenetic levels, and are involved in controlling cell growth, differentiation, apoptosis, immune response, and maintaining homeostasis. These molecules are diverse, including microRNA, long non-coding RNA, circular RNA, small interfering RNA, and other types that play specialized roles in regulating gene networks. Recent research has shown that disruptions in the expression of these molecules are closely linked to the development of many diseases, including cancer, cardiovascular diseases, neurodegenerative disorders, and immune and metabolic diseases. In recent years, non-coding RNA has become a major focus in precision medicine due to its great potential as a highly sensitive and specific biomarker for early diagnosis, predicting disease course, and assessing therapeutic response, as well as its role as a promising therapeutic target in the development of modern molecular therapies.
References
1. Pope, S. D., & Medzhitov, R. (2018). Emerging Principles of Gene Expression Programs and Their Regulation. Molecular Cell, 71(3), 389–397. https://doi.org/10.1016/j.molcel.2018.07.017
2. Mousa, Z. Q. (2022). Genetic Polymorphisms in β-Thalassemia Major in Misan. Ministry
of Higher Education.
3. Maroto, M., Torvisco, S. N., García-Merino, C., Fernández-González, R., & Pericuesta, E. (2025). Mechanisms of Hormonal, Genetic, and Temperature Regulation of Germ Cell Proliferation, Differentiation, and Death During Spermatogenesis. Biomolecules, 15(4), 500. https://doi.org/10.3390/biom15040500
4. Amaral, P., Carbonell-Sala, S., De La Vega, F. M., Faial, T., Frankish, A., Gingeras, T., Guigo, R., Harrow, J. L., Hatzigeorgiou, A. G., Johnson, R., Murphy, T. D., Pertea, M., Pruitt, K. D., Pujar, S., Takahashi, H., Ulitsky, I., Varabyou, A., Wells, C. A., Yandell, M., … Salzberg, S. L. (2023). The status of the human gene catalogue. Nature, 622(7981), 41–47. https://doi.org/10.1038/s41586-023-06490-x
5. Alzarea, S. I. (2025). Non-coding RNA-mediated gene regulation in Alzheimer’s disease pathogenesis: molecular insights and emerging innovations. Saudi Pharmaceutical Journal, 33(5), 33. https://doi.org/10.1007/s44446-025-00026-2
6. Mousa, Z. Q., & Dragh, M. A. (2023). The Study of BCL11A Gene in Patients with Beta-Thalassemia Major and Intermedia by Random Amplephed Polymorphism DNA in Iraq.
7. Li, Y. (2023). Non–Coding RNA Performs Its Biological Function by Interacting with Macromolecules. In International Journal of Molecular Sciences (Vol. 24, Issue 22, p. 16246). MDPI. https://doi.org/10.3390/ijms242216246
8. Márton, É., Varga, A., Domoszlai, D., Buglyó, G., Balázs, A., Penyige, A., Balogh, I., Nagy, B., & Szilágyi, M. (2025). Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application. Cancers, 17(4), 579. https://doi.org/10.3390/cancers17040579
9. Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024). Non-coding RNAs in disease: from mechanisms to therapeutics. Nature Reviews Genetics, 25(3), 211–232. https://doi.org/10.1038/s41576-023-00662-1
10. Nadhan, R., Isidoro, C., Song, Y. S., & Dhanasekaran, D. N. (2022). Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology. Cells, 11(16), 2517. https://doi.org/10.3390/cells11162517
11. Pathania, A. S., Chava, H., Balusu, R., Pasupulati, A. K., Coulter, D. W., & Challagundla, K. B. (2024). The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy. Molecular Therapy Oncology, 32(2). https://doi.org/10.1016/j.omton.2024.200785
12. Ginckels, P., & Holvoet, P. (2022). Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs. Yale Journal of Biology and Medicine, 95(1), 129–152.
13. Zhang, Y., Liu, H., Niu, M., Wang, Y., Xu, R., Guo, Y., & Zhang, C. (2024). Roles of long noncoding RNAs in human inflammatory diseases. Cell Death Discovery, 10(1), 235. https://doi.org/10.1038/s41420-024-02002-6
14. Afroze, N., Sundaram, M. K., Haque, S., & Hussain, A. (2025). Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review. Discover Oncology, 16(1), 122. https://doi.org/10.1007/s12672-025-01848-1
15. Xie, Y., & Wei, Y. (2021). A novel regulatory player in the innate immune system: Long non-coding RNAs. International Journal of Molecular Sciences, 22(17), 9535. https://doi.org/10.3390/ijms22179535
16. Kumar, L., Shamsuzzama, Haque, R., Baghel, T., & Nazir, A. (2017). Circular RNAs: the Emerging Class of Non-coding RNAs and Their Potential Role in Human Neurodegenerative Diseases. Molecular Neurobiology, 54(9), 7224–7234. https://doi.org/10.1007/s12035-016-0213-8
17. Lodde, V., Murgia, G., Simula, E. R., Steri, M., Floris, M., & Idda, M. L. (2020). Long noncoding RNAs and circular RNAs in autoimmune diseases. Biomolecules, 10(7), 1–22. https://doi.org/10.3390/biom10071044
18. Smith, E. S., Whitty, E., Yoo, B., Moore, A., Sempere, L. F., & Medarova, Z. (2022). Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. Cancers, 14(6), 1588. https://doi.org/10.3390/cancers14061588
19. Anfossi, S., Babayan, A., Pantel, K., & Calin, G. A. (2018). Clinical utility of circulating non-coding RNAs — an update. Nature Reviews Clinical Oncology, 15(9), 541–563. https://doi.org/10.1038/s41571-018-0035-x
20. Abuhaliema, A., Gharaibeh, L., Jaradat, E., Hammad, M., & Alshaer, W. (2026). Non-coding RNAs in gene therapy: mechanisms, delivery strategies, and clinical translation. Pharmacia, 73(73), 1–25. https://doi.org/10.3897/pharmacia.73.e173259
21. Mattick, J. S., & Makunin, I. V. (2006). Non-coding RNA. Human Molecular Genetics, 15(suppl_1), R17–R29.
22. Oo, J. A., Brandes, R. P., & Leisegang, M. S. (2022). Long non-coding RNAs: novel regulators of cellular physiology and function. Pflugers Archiv European Journal of Physiology, 474(2), 191–204. https://doi.org/10.1007/s00424-021-02641-z
23. Abdul-Sahib, R. J., & Faraj, S. H. (2023). Molecular Analysis Of Cyp17 Gene Promoter In Iraqi Infertile Women. Ann. For. Res, 66(1), 2518–2525.
24. Walter, N. G. (2024). Are non-protein coding RNAs junk or treasure?: An attempt to explain and reconcile opposing viewpoints of whether the human genome is mostly transcribed into non-functional or functional RNAs. BioEssays, 46(4), 2300201. https://doi.org/10.1002/bies.202300201
25. Marguerat, S., & Bähler, J. (2010). RNA-seq: From technology to biology. Cellular and Molecular Life Sciences, 67(4), 569–579. https://doi.org/10.1007/s00018-009-0180-6
26. Sempere, L. F. (2019). Celebrating 25 years of microRNA research: From discovery to clinical application. In International Journal of Molecular Sciences (Vol. 20, Issue 8, p. 1987). MDPI. https://doi.org/10.3390/ijms20081987
27. Werstruck, G., & Green, M. R. (1999). Controlling gene expression in living cells through small molecule-RNA interactions. Chemtracts, 12(11), 803–807.
28. Ruffo, P., Traynor, B. J., & Conforti, F. L. (2025). Unveiling the regulatory potential of the non-coding genome: Insights from the human genome project to precision medicine. Genes and Diseases, 12(6), 101652. https://doi.org/10.1016/j.gendis.2025.101652
29. Charan, P., Joseph, A., Ebenezer, P., Sankar, V., Suravajhala, R., Rao, R. S. P., & Suravajhala, P. (2025). An introduction to non-coding RNAs. Progress in Molecular Biology and Translational Science, 214, 1–17.
30. Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010). Regulation of mRNA translation and stability by microRNAs. Annual Review of Biochemistry, 79(1), 351–379. https://doi.org/10.1146/annurev-biochem-060308-103103
31. Li, M., Marin-Muller, C., Bharadwaj, U., Chow, K. H., Yao, Q., & Chen, C. (2009). MicroRNAs: Control and loss of control in human physiology and disease. World Journal of Surgery, 33(4), 667–684. https://doi.org/10.1007/s00268-008-9836-x
32. Yan, H., & Bu, P. (2021). Non-coding RNA in cancer. Essays in Biochemistry, 65(4), 625–639. https://doi.org/10.1042/EBC20200032
33. Mattick, J. S., Amaral, P. P., Carninci, P., Carpenter, S., Chang, H. Y., Chen, L.-L., Chen, R., Dean, C., Dinger, M. E., & Fitzgerald, K. A. (2023). Long non-coding RNAs: definitions, functions, challenges and recommendations. Nature Reviews Molecular Cell Biology, 24(6), 430–447.
34. Statello, L., Guo, C. J., Chen, L. L., & Huarte, M. (2021). Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology, 22(2), 96–118. https://doi.org/10.1038/s41580-020-00315-9
35. Fernandes, J. C. R., Acuña, S. M., Aoki, J. I., Floeter-Winter, L. M., & Muxel, S. M. (2019). Long non-coding RNAs in the regulation of gene expression: Physiology and disease. Non-Coding RNA, 5(1), 17. https://doi.org/10.3390/ncrna5010017
36. Déctor, M. A., Romero, P., López, S., & Arias, C. F. (2002). Rotavirus gene silencing by small interfering RNAs. EMBO Reports, 3(12), 1175–1180. https://doi.org/10.1093/embo-reports/kvf234
37. Rana, T. M. (2007). Illuminating the silence: Understanding the structure and function of small RNAs. Nature Reviews Molecular Cell Biology, 8(1), 23–36. https://doi.org/10.1038/nrm2085
38. Matera, A. G., Terns, R. M., & Terns, M. P. (2007). Non-coding RNAs: Lessons from the small nuclear and small nucleolar RNAs. Nature Reviews Molecular Cell Biology, 8(3), 209–220. https://doi.org/10.1038/nrm2124
39. Kiss, T. (2004). Biogenesis of small nuclear RNPs. Journal of Cell Science, 117(25), 5949–5951. https://doi.org/10.1242/jcs.01487
40. Xu, G., Xu, W. Y., Xiao, Y., Jin, B., Du, S. Da, Mao, Y. L., & Zhang, Z. T. (2020). The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma. Cancer Cell International, 20(1), 496. https://doi.org/10.1186/s12935-020-01581-5
41. Thomson, D. W., & Dinger, M. E. (2016). Endogenous microRNA sponges: Evidence and controversy. Nature Reviews Genetics, 17(5), 272–283. https://doi.org/10.1038/nrg.2016.20
42. Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2017). Non-coding RNA networks in cancer. Nature Reviews Cancer, 18(1), 5–18. https://doi.org/10.1038/nrc.2017.99
43. Wang, W., Min, L., Qiu, X., Wu, X., Liu, C., Ma, J., Zhang, D., & Zhu, L. (2021). Biological Function of Long Non-coding RNA (LncRNA) Xist. Frontiers in Cell and Developmental Biology, 9, 645647. https://doi.org/10.3389/fcell.2021.645647
44. Allis, C. D., & Jenuwein, T. (2016). The molecular hallmarks of epigenetic control. Nature Reviews Genetics, 17(8), 487–500. https://doi.org/10.1038/nrg.2016.59
45. O’Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018). Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in Endocrinology, 9(AUG), 402. https://doi.org/10.3389/fendo.2018.00402
46. Saliminejad, K., Khorram Khorshid, H. R., Soleymani Fard, S., & Ghaffari, S. H. (2019). An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. Journal of Cellular Physiology, 234(5), 5451–5465. https://doi.org/10.1002/jcp.27486
47. Qi, P., Zhou, X. yan, & Du, X. (2016). Circulating long non-coding RNAs in cancer: Current status and future perspectives. Molecular Cancer, 15(1), 39. https://doi.org/10.1186/s12943-016-0524-4
48. Peng, Y., & Croce, C. M. (2016). The role of microRNAs in human cancer. Signal Transduction and Targeted Therapy, 1(1), 15004. https://doi.org/10.1038/sigtrans.2015.4
49. Cai, Z., Liu, M., Zeng, L., Zhao, K., Wang, C., Sun, T., Li, Z., & Liu, R. (2023). Role of traditional Chinese medicine in ameliorating mitochondrial dysfunction via non-coding RNA signaling: Implication in the treatment of neurodegenerative diseases. Frontiers in Pharmacology, 14, 1123188. https://doi.org/10.3389/fphar.2023.1123188
50. Wang, R. C., & Wang, Z. (2023). Precision Medicine: Disease Subtyping and Tailored Treatment. Cancers, 15(15), 3837. https://doi.org/10.3390/cancers15153837
51. Van Roosbroeck, K., Pollet, J., & Calin, G. A. (2013). MiRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Review of Molecular Diagnostics, 13(2), 183–204. https://doi.org/10.1586/erm.12.134
52. Setyati, R., Astuti, A., Putri Utami, T., Adiwijaya, S., Muhammad Hasyim, D., Tinggi Ilmu Kesehatan Kesosi, S., & Author, C. (2024). The Importance of Early Detection in Disease Management. Journal of World Future Medicine, 2(1), 51–63. https://doi.org/10.55849/health.v2i1.692
53. Zhou, S., Li, J., Yang, W., Xue, P., Yin, Y., Wang, Y., Tian, P., Peng, H., Jiang, H., Xu, W., Huang, S., Zhang, R., Wei, F., Sun, H. X., Zhang, J., & Zhao, L. (2023). Noninvasive preeclampsia prediction using plasma cell–free RNA signatures. American Journal of Obstetrics and Gynecology, 229(5), 553.e1-553.e16. https://doi.org/10.1016/j.ajog.2023.05.015
54. Hossam Abdelmonem, B., Kamal, L. T., Wardy, L. W., Ragheb, M., Hanna, M. M., Elsharkawy, M., & Abdelnaser, A. (2025). Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases. Frontiers in Oncology, 15, 1534862. https://doi.org/10.3389/fonc.2025.1534862
55. Chen, B. Q., Dragomir, M. P., Yang, C., Li, Q., Horst, D., & Calin, G. A. (2022). Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduction and Targeted Therapy, 7(1), 121. https://doi.org/10.1038/s41392-022-00975-3
56. Liu, K., Gao, L., Ma, X., Huang, J. J., Chen, J., Zeng, L., Ashby, C. R., Zou, C., & Chen, Z. S. (2020). Long non-coding RNAs regulate drug resistance in cancer. Molecular Cancer, 19(1), 54. https://doi.org/10.1186/s12943-020-01162-0
57. Coan, M., Haefliger, S., Ounzain, S., & Johnson, R. (2024). Targeting and engineering long non-coding RNAs for cancer therapy. Nature Reviews Genetics, 25(8), 578–595. https://doi.org/10.1038/s41576-024-00693-2
58. Jamalinia, M., & Weiskirchen, R. (2025). Advances in personalized medicine: translating genomic insights into targeted therapies for cancer treatment. Annals of Translational Medicine, 13(2), 18–18. https://doi.org/10.21037/atm-25-34
59. Jung, V., Vincent-Cuaz, C., Tumescheit, C., Fournier, L., Darsinou, M., Xu, Z. M., Saadat, A., Wang, Y., Tsantoulis, P., Michielin, O., Fellay, J., Patani, R., Ramos, A., Frossard, P., Hastings, J., Riccio, A., van der Plas, L., & Luisier, R. (2025). Decoding the interactions and functions of non-coding RNA with artificial intelligence. Nature Reviews Molecular Cell Biology, 26(10), 797–818. https://doi.org/10.1038/s41580-025-00857-w
60. Micheel, J., Safrastyan, A., & Wollny, D. (2021). Advances in non-coding RNA sequencing. Non-Coding RNA, 7(4), 70. https://doi.org/10.3390/ncrna7040070
61. Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022). MicroRNA-based diagnosis and therapy. International Journal of Molecular Sciences, 23(13), 7167.
62. Abd-Aziz, N., Kamaruzman, N. I., & Poh, C. L. (2020). Development of MicroRNAs as Potential Therapeutics against Cancer. Journal of Oncology, 2020(1), 8029721. https://doi.org/10.1155/2020/8029721
63. Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020). Therapeutic siRNA: state of the art. Signal Transduction and Targeted Therapy, 5(1), 101.
64. Bobbin, M. L., & Rossi, J. J. (2016). RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise? Annual Review of Pharmacology and Toxicology, 56(1), 103–122. https://doi.org/10.1146/annurev-pharmtox-010715-103633
65. Yi, Q., Feng, J., Lan, W., shi, H., Sun, W., & Sun, W. (2024). CircRNA and lncRNA-encoded peptide in diseases, an update review. Molecular Cancer, 23(1), 214. https://doi.org/10.1186/s12943-024-02131-7
66. Loganathan, T., & Doss C, G. P. (2023). Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. Functional and Integrative Genomics, 23(1), 33. https://doi.org/10.1007/s10142-022-00947-4
67. Pozdniakova, N., Generalov, E., Shevelev, A., & Tarasova, O. (2025). RNA Therapeutics: Delivery Problems and Solutions—A Review. Pharmaceutics, 17(10), 1305. https://doi.org/10.3390/pharmaceutics17101305
68. Eygeris, Y., Gupta, M., Kim, J., & Sahay, G. (2022). Chemistry of Lipid Nanoparticles for RNA Delivery. Accounts of Chemical Research, 55(1), 2–12. https://doi.org/10.1021/acs.accounts.1c00544
69. Jabbar, R. (2026). Association Between Age, Body Mass Index, and Hypertension Among Adults in Maysan Governorate, Iraq: A Cross-Sectional Study. Libyan Journal of Applied and Contemporary Sciences, 1(2), 50–58. https://doi.org/10.64943/ljacs.2026.010205
70. Samanta, S., Rajasingh, S., Drosos, N., Zhou, Z., Dawn, B., & Rajasingh, J. (2018). Exosomes: New molecular targets of diseases. Acta Pharmacologica Sinica, 39(4), 501–513. https://doi.org/10.1038/aps.2017.162
71. Muskan, M., Abeysinghe, P., Cecchin, R., Branscome, H., Morris, K. V., & Kashanchi, F. (2024). Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles. Molecular Therapy, 32(9), 2939–2949. https://doi.org/10.1016/j.ymthe.2024.02.025
72. Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021). Noncoding RNA therapeutics — challenges and potential solutions. Nature Reviews Drug Discovery, 20(8), 629–651. https://doi.org/10.1038/s41573-021-00219-z
73. Bougea, A. (2026). Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases. International Journal of Molecular Sciences, 27(7), 3260. https://doi.org/10.3390/ijms27073260
74. Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K. (2011). Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovascular Research, 90(3), 430–440. https://doi.org/10.1093/cvr/cvr097
75. Altayli, E. (2020). Regulator non-coding RNAs: miRNA, siRNA, piRNA, lncRNA, circRNA. Journal of Clinical Medicine of Kazakhstan, 6 (60), 29–39.
76. Eldakhakhny, B., Sutaih, A. M., Siddiqui, M. A., Aqeeli, Y. M., Awan, A. Z., Alsayegh, M. Y., Elsamanoudy, S. A., & Elsamanoudy, A. (2024). Exploring the role of noncoding RNAs in cancer diagnosis, prognosis, and precision medicine. Non-Coding RNA Research, 9(4), 1315–1323. https://doi.org/10.1016/j.ncrna.2024.06.015
77. Uppaluri, K. R., Challa, H. J., Gaur, A., Jain, R., Krishna Vardhani, K., Geddam, A., Natya, K., Aswini, K., Palasamudram, K., & K, S. M. (2023). Unlocking the potential of non-coding RNAs in cancer research and therapy. Translational Oncology, 35, 101730. https://doi.org/10.1016/j.tranon.2023.101730
78. Tingö, L., Ahlberg, E., Johansson, L., Pedersen, S. A., Chawla, K., Sætrom, P., Cione, E., & Simpson, M. R. (2021). Non-Coding RNAs in Human Breast Milk: A Systematic Review. Frontiers in Immunology, 12, 725323. https://doi.org/10.3389/fimmu.2021.725323
79. Piergentili, R., Basile, G., Nocella, C., Carnevale, R., Marinelli, E., Patrone, R., & Zaami, S. (2022). Using ncRNAs as Tools in Cancer Diagnosis and Treatment—The Way towards Personalized Medicine to Improve Patients’ Health. International Journal of Molecular Sciences, 23(16), 9353. https://doi.org/10.3390/ijms23169353
80. Forterre, A., Komuro, H., Aminova, S., & Harada, M. (2020). A comprehensive review of cancer microRNA therapeutic delivery strategies. Cancers, 12(7), 1–21. https://doi.org/10.3390/cancers12071852
81. Yetgin, A. (2025). Revolutionizing multi-omics analysis with artificial intelligence and data processing. Quantitative Biology, 13(3), e70002. https://doi.org/10.1002/qub2.70002
Downloads
Published
How to Cite
License
Copyright (c) 2026 Libyan Journal of Applied and Contemporary Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
